AllQuantitative Report
logoArgusMay 05, 2021

CYTK: Lowering target price to $25.00

Symbols
CYTK
Sector(s)
Healthcare
Rating
Current Price
$21.93
Price Target
$NaN
Earnings Estimate
Summary

Cytokinetics Inc is a biotechnology company that develops muscle biology-driven treatments for diseases characterized by reduced muscle function, muscle weakness, and fatigue.

Subscribe to Yahoo Finance Plus Essential for full access
Exclusive reports, detailed company profiles, and best-in-class trade insights to take your portfolio to the next level
Try it Free